Interestingly, a significant downregulation of APOA4 and a decreased number of APOA4‐positive hepatocytes around the portal triad were observed in IUGR males treated with ICA compared with IUGR males (Figure 8g–i). The gene discussed is APOA4; the disease is fetal growth restriction.